0.2405
price down icon3.68%   -0.0092
pre-market  Vorhandelsmarkt:  .24   -0.0005   -0.21%
loading
Schlusskurs vom Vortag:
$0.2497
Offen:
$0.244
24-Stunden-Volumen:
616.95K
Relative Volume:
0.04
Marktkapitalisierung:
$2.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.53M
KGV:
-0.0499
EPS:
-4.82
Netto-Cashflow:
$-11.12M
1W Leistung:
+10.88%
1M Leistung:
-12.55%
6M Leistung:
-67.05%
1J Leistung:
-86.06%
1-Tages-Spanne:
Value
$0.2351
$0.247
1-Wochen-Bereich:
Value
$0.2071
$0.2689
52-Wochen-Spanne:
Value
$0.15
$3.10

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name
Firmenname
Processa Pharmaceuticals Inc
Name
Telefon
443-776-3133
Name
Adresse
7380 COCA COLA DRIVE, HANOVER
Name
Mitarbeiter
13
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
PCSA's Discussions on Twitter

Vergleichen Sie PCSA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PCSA
Processa Pharmaceuticals Inc
0.2405 6.54M 0 -11.53M -11.12M -4.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-25 Eingeleitet H.C. Wainwright Buy

Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten

pulisher
Jul 23, 2025

What drives Processa Pharmaceuticals Inc. stock priceDynamic profit opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Processa Pharmaceuticals Inc. stockExceptional profit potential - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Processa Pharmaceuticals Inc. Stock Analysis and ForecastRecord-breaking capital gains - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Processa Pharmaceuticals Inc (PCSA) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Processa Pharmaceuticals Inc. stock price move sharplyFree Wealth-Building Investment Strategies - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

Is Processa Pharmaceuticals Inc. a good long term investmentRecord-breaking gains - Autocar Professional

Jul 19, 2025
pulisher
Jul 19, 2025

Processa Pharmaceuticals Approves Key Proposals at Annual Meeting - The Globe and Mail

Jul 19, 2025
pulisher
Jul 18, 2025

RedChip Showcases Processa Pharmaceuticals and BullFrog AI on Bloomberg TV - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Processa Pharmaceuticals and BullFrog AI Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Des Moines Register

Jul 18, 2025
pulisher
Jul 18, 2025

The Convergence of AI and Biotech: BullFrog AI and Processa Pharmaceuticals as Catalysts for Disruption - AInvest

Jul 18, 2025
pulisher
Jul 16, 2025

How Processa Pharmaceuticals Inc. stock performs during market volatilityTrend Following Trades - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Processa Pharmaceuticals Inc. stock attracts strong analyst attentionCarefully Curated High Return Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals Reschedules Annual Shareholder Meeting - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals to reconvene annual meeting after achieving quorum By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Processa Pharmaceuticals to reconvene annual meeting after achieving quorum - Investing.com

Jul 15, 2025
pulisher
Jul 13, 2025

Processa Pharmaceuticals, Inc. (PCSA) Secures Buy Rating on Portfolio Progress - MSN

Jul 13, 2025
pulisher
Jul 11, 2025

Processa Pharmaceuticals: Betting on Catalyst-Driven Value Acceleration - AInvest

Jul 11, 2025
pulisher
Jul 09, 2025

Processa Stock Soars 33.96% on Penny Stock Inclusion - AInvest

Jul 09, 2025
pulisher
Jul 09, 2025

Processa Stock Soars 14.62% on Penny Stock Inclusion - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

12 Best Fundamentally Strong Penny Stocks to Invest in - Insider Monkey

Jul 08, 2025
pulisher
Jul 03, 2025

Processa Pharmaceuticals stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com UK

Jul 03, 2025
pulisher
Jul 02, 2025

Processa terminates license agreement for PCS3117 - TipRanks

Jul 02, 2025
pulisher
Jul 01, 2025

Processa Pharmaceuticals adjourns annual meeting due to lack of quorum By Investing.com - Investing.com UK

Jul 01, 2025
pulisher
Jun 30, 2025

Processa Pharmaceuticals adjourns annual meeting due to lack of quorum - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Processa Pharmaceuticals Adjourns Annual Shareholder Meeting - TipRanks

Jun 30, 2025
pulisher
Jun 23, 2025

Processa Pharmaceuticals Plunges 15.31% Amid Market Volatility - AInvest

Jun 23, 2025
pulisher
Jun 20, 2025

Rx Rundown: Sanofi, Processa Pharmaceuticals, Eli Lilly and more - Medical Marketing and Media

Jun 20, 2025
pulisher
Jun 18, 2025

Processa Pharmaceuticals Announces Public Offering Pricing - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Processa inks licensing deal with Intact for gastroparesis drug By Investing.com - Investing.com India

Jun 18, 2025

Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Processa Pharmaceuticals Inc-Aktie (PCSA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Ng George K
Chief Executive Officer
Jan 27 '25
Buy
0.80
87,200
69,542
87,200
Young David
Pres. Research & Development
Jan 27 '25
Buy
0.80
124,500
99,289
205,405
Lin Patrick
Chief Business - Strategy Off
Jan 27 '25
Buy
0.80
43,500
34,691
43,500
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Kapitalisierung:     |  Volumen (24h):